Parkinson’s disease (PD) is a chronic, progressive neurodegenerative movement disorder fundamentally driven by the severe loss of dopaminergic neurons in the substantia nigra pars compacta (a core structure in the basal ganglia) and the widespread accumulation of misfolded alpha-synuclein protein aggregates known as Lewy bodies. This profound dopamine deficiency disrupts the brain’s complex motor control circuitry, producing the classic clinical motor triad: bradykinesia (slowness of voluntary movement), resting tremor (often starting as an asymmetric “pill-rolling” tremor in one hand), and muscle rigidity (cogwheel or lead-pipe stiffness). As the disease advances, patients frequently develop postural instability, a shuffling or festinating gait, masked facies (hypomimia), and hypophonia (a very soft, breathy voice). Non-motor symptoms are equally debilitating and include REM sleep behavior disorder, severe constipation, anosmia (loss of smell), autonomic dysfunction, and eventual Parkinson’s disease dementia. Clinical Indicators: For coding and documentation, it is no longer sufficient to document simply “Parkinson’s disease.” Following the FY2024 ICD-10-CM update, the parent code G20 is no longer billable. Coders must now meticulously search neurology and HPI documentation for the presence or absence of dyskinesia (involuntary, writhing, choreic movements typically induced by long-term levodopa therapy) and the presence of fluctuations or “ON/OFF” episodes (predictable or unpredictable variations in medication efficacy and motor function throughout the day). Without these explicit descriptors, claims must default to unspecified parkinsonism.
Named after James Parkinson, the English apothecary, physician, and paleontologist who first formally described the condition as a distinct medical syndrome in his highly influential 1817 work, An Essay on the Shaking Palsy.
Literally: The disease itself is an eponym honoring the physician who defined it, but its primary clinical descriptors (bradykinesia, dyskinesia) are derived from Greek roots defining the abnormalities in human motion. Historically, the disease was termed paralysis agitans (Latin for “shaking palsy”), a term coined by Parkinson himself to describe the paradoxical combination of diminished voluntary motor power (paresis/paralysis) coupled with constant, involuntary resting tremors (agitans).
🔀 ALIASES / ALTERNATE TERMS
Term
Context
PD
The universal clinical abbreviation for Parkinson’s disease.
Idiopathic parkinsonism
A medically precise synonym confirming that the symptoms arise spontaneously without an external/secondary cause (like drugs or strokes).
Paralysis agitans
The original, historical Latin name; largely obsolete in modern charting but remains indexed in ICD-10-CM.
Shaking palsy
An antiquated, historical layperson term.
🔗 RELATED TERMS
Secondary parkinsonism — G21.9 (unspecified) or G21.11 (neuroleptic-induced); drug-induced, vascular, or post-encephalitic motor symptoms mimicking PD, but caused by a specific external insult rather than idiopathic neurodegeneration.
Dementia with Lewy bodies (DLB) — G31.83; a related synucleinopathy where dementia and visual hallucinations develop before or concurrently with parkinsonian motor symptoms, whereas in PD, motor symptoms typically precede dementia by many years.
Essential tremor — G25.0; a very common movement disorder characterized by an action or postural tremor (worsening when trying to use the hands), distinct from the resting tremor of PD.
Bradykinesia — The neurological symptom of generalized movement slowness; a mandatory diagnostic criteria for diagnosing true Parkinson’s disease.
Dyskinesia — Involuntary, erratic, writhing movements of the face, arms, legs, or trunk. In PD, it is almost entirely a complication of long-term Levodopa medication usage, not a symptom of the disease itself.
Deep Brain Stimulation (DBS) — A neurosurgical treatment for advanced PD involving implanted electrodes that modulate the abnormal basal ganglia signals to drastically reduce tremor, rigidity, and dyskinesia.
⚠️ ICD-10-CM / Chapter Nuances: G20 is a parent code and is NO LONGER BILLABLE. As of the FY2024 updates, coders must select a subcode based on the documented presence/absence of dyskinesia and fluctuations (also called “ON/OFF” episodes). If neither is mentioned, default to the unspecified code.
Parkinson’s disease without dyskinesia, without mention of fluctuations (Use when PD is documented simply, and the patient does not exhibit involuntary writhing or ON/OFF periods)
Parkinson’s disease without dyskinesia, with fluctuations (Use when the patient has predictable or unpredictable “wearing off” of their medication effectiveness)
Parkinson’s disease with dyskinesia, without mention of fluctuations (Use when the patient experiences Levodopa-induced writhing movements, but no wearing-off)
Parkinsonism, unspecified (Use as a last resort if “parkinsonism” is charted without specifying whether it is idiopathic PD or a secondary variant)
Common Manifestations & Complications
⚠️ Instructional Note: Parkinson’s is frequently accompanied by dementia or swallowing disorders. When dementia is present, ICD-10 requires the underlying physiological condition (the PD) to be coded first.
Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety (A mandatory secondary code if “Parkinson’s disease dementia” is diagnosed)
Neuroleptic induced parkinsonism (Differential code: Use this if the motor symptoms are explicitly caused by psychiatric antipsychotic medications, NOT G20.-)
🔧 COMMON CPT CODES (Evaluation, Surgery & Rehabilitation)
Deep Brain Stimulation (DBS) Surgery
⚠️ CPT Nuance: DBS typically occurs in two stages: brain electrode placement (Stereotactic), followed days/weeks later by the chest pacemaker placement (Pulse Generator).
Twist drill, burr hole, craniotomy, or craniectomy with stereotactic implantation of neurostimulator electrode array in basal ganglia, thalamus, globus pallidus, pectoral forebrain, with use of intraoperative microelectrode recording; first array
Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array
Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities (Extensively used for LSVT BIG physical therapy protocols designed specifically for PD)
Bilateral procedure — Used if certain unlisted or specific neurological assessments/procedures are performed on both sides, though for DBS electrode placement, 61868 is the designated add-on code for the second array.
Significant, separately identifiable E&M service — Append to an established patient visit (e.g., 99214) if the neurologist performs a significant E&M on the same day they also actively reprogram a DBS neurostimulator.
⚠️ Coding Note: The biggest revenue and compliance risk in coding Parkinson’s disease currently lies in relying on outdated cheat sheets containing G20. Claim rejections are virtually guaranteed if G20 is submitted without the A/B/C sub-character extensions required as of late 2023. If a physician’s note simply says “PD, doing well on Sinemet,” it defaults to G20.A1. However, if the note indicates the patient is experiencing “wearing off before their next dose” or “mild chorea an hour after dosing,” this is the vital clinical documentation needed to upgrade the code to an A2, B1, or B2 tier. When coding for dementia in a Parkinson’s patient, remember the ICD-10 sequencing rule: the etiology (the Parkinson’s code) must be sequenced first, followed immediately by the psychiatric manifestation (the F02.- code).
Crystal's MCW Coder Hub